The Prevalances and Patient Characteristics of Primary Immunodeficiency Diseases in Turkey-Two Centers Study

dc.contributor.authorKilic, Sara S.
dc.contributor.authorOzel, Mustafa
dc.contributor.authorHafizoglu, Demet
dc.contributor.authorKaraca, Neslihan Edeer
dc.contributor.authorAksu, Guzide
dc.contributor.authorKutukculer, Necil
dc.date.accessioned2019-10-27T21:55:34Z
dc.date.available2019-10-27T21:55:34Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description.abstractPurpose Primary immunodeficiency diseases (PIDs) are inherited disorders of the immune system resulting in increased susceptibility to unusual infections and predisposition to autoimmunity and malignancies. The European Society for Immunodeficiencies (ESID) has developed an internet-based database for clinical and research data on patients with PID. This study aimed to provide a minimum estimate of the prevalence of each disorder and to determine the clinical characteristics and outcomes of patients with PID in Turkey. Methods Clinical features of 1435 patients with primary immunodeficiency disorders are registered in ESID Online Patient Registry by the Pediatric Immunology Departments of the Medical Faculties of Uludag University and Ege University Between 2004 and 2010. These two centers are the major contributors reporting PID patients to ESID database from Turkey. Results Predominantly antibody immunodeficiency (73.9 %) was the most common category followed by autoinflammatory disorders (13.3 %), other well defined immunodeficiencies (5.5 %), congenital defects of phagocyte number, function or both (3.5 %), combined T and B cell immunodeficiencies (2 %), defects in innate immunity (1 %), and diseases of immune dysregulation (0.7 %) and complement deficiencies (0.4 %). Patients between 0 and 18 years of age constitued 94 % of total and the mean age was 9.2 +/- 6 years. The consanguinity rate within the registered patients was 14.3 % (188 of 1130 patients). The prevalance of all PID cases ascertained from the registry was 30.5/100.000. The major cause of the mortality was severe infection which was seen in forty-two of seventy five deceased patients. The highest mortality was observed in patients with severe combined immunodeficiencies and ataxia-telangiectasia. Conclusion Promoting the awareness of PID among the medical professionals and the general public is required if premature death and serious morbidity occurs due to late diagnosis of the wider spectrum of PID are to be avoided.en_US
dc.identifier.doi10.1007/s10875-012-9763-3en_US
dc.identifier.endpage83en_US
dc.identifier.issn0271-9142
dc.identifier.issue1en_US
dc.identifier.pmid22983506en_US
dc.identifier.startpage74en_US
dc.identifier.urihttps://doi.org/10.1007/s10875-012-9763-3
dc.identifier.urihttps://hdl.handle.net/11454/48243
dc.identifier.volume33en_US
dc.identifier.wosWOS:000323117100010en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer/Plenum Publishersen_US
dc.relation.ispartofJournal of Clinical Immunologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRegistryen_US
dc.subjectESIDen_US
dc.subjectonline databaseen_US
dc.subjectprimary immunodeficiencyen_US
dc.subjectTurkeyen_US
dc.titleThe Prevalances and Patient Characteristics of Primary Immunodeficiency Diseases in Turkey-Two Centers Studyen_US
dc.typeArticleen_US

Dosyalar